Rolimus 5mg belongs to a class of anti-cancer drugs
Rolimus 5 MG Tablet is an immuno-suppressant which is used in kidney, liver, and heart transplant patients. It ought to be used underneath the management of a professional medical practitioner.
Close observance of the vital signs is critical whereas receiving these drugs.
Rolimus 5mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down.
Rolimus 5mg tablets is not a curable medication, which helps to slow their spreading into the body.
PRESCRIBED FOR
The drug Rolimus 5mg is mainly used for the treatment of the following disease
• kidney carcinoma
• Breast carcinoma
• Brain carcinoma
Rolimus 5mg is also used to treat various advanced-stage cancer in the stomach, intestines or pancreas.
MECHANISM
Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to a stoppage of cell progression from G1 into the S phase, finally causes cell growth arrest and apoptosis. Rolimus also prohibits the expression of hypoxia-inducible factors, causing a reduces in the expression of vascular endothelial growth factor. The result of the everolimus prevention of mTOR is a reduction in cell multiplication, angiogenesis, and glucose uptake.
DOSAGE
Rolimus 5mg tablets should be given with or without food.
The dosage regimen of Rolimus:
In breast cancer, renal cell cancer, pancreatic cancer, Neuroendocrine cancer
The prescribed dosage is 10mg should be taken as a single dose. In Brain or intracranial cancer
The prescribed dosage of Rolimus as a single dose. is 4.5mg/m2 given orally
In pediatric:
The pediatric dosage of Rolimus as a single dose in the brain or intracranial tumor is 4.5mg/m2 should be given orally.
SIDE EFFECTS
• Nephrotoxicity
• Thrombocytopenia
• Hypersensitivity reactions
• Hyperlipemia
• Angioedema
• Lymphomas & other malignancy
• Male infertility
DRUG-DRUG INTERACTION
Interaction of Rolimus 5mg with strong inhibitor of CYP3A4, or P-gp, cause reducing the efflux of Everolimus and high plasma concentration of Everolimus.
Concomitant use of Rolimus 5mg with strong CYP3A4 inducers will be increasing the disclosure of Everolimus.
Interaction of Rolimus 5mg with cyclosporine will be increasing the AUC level of Everolimus frequently. Interaction of ketoconazole with Rolimus 5mg tablet or other CYP3A4 inhibitors will increase the plasma concentration and AUC of Everolimus.
PREGNANCY
Pregnancy category of Everolimus C: In patients, Rolimus 5mg is used only after knowing the benefits to the mother exceed the risk to the fetus.
LACTATION
Breastfeeding should not be suggested
STORAGE
Rolimus 5mg tablet store at 25°C
Protect the drugs removed from wetness, heat, and light.
MISSED DOSE
If the patients missed the dose, patients must consult with the medical practitioner and follow the instructions given by them. Or missed dose should be avoided and follow the regular dosing schedule.
Rolimus 5 MG Tablet is an immuno-suppressant which is used in kidney, liver, and heart transplant patients. It ought to be used underneath the management of a professional medical practitioner.
Close observance of the vital signs is critical whereas receiving these drugs.
Rolimus 5mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down.
Rolimus 5mg tablets is not a curable medication, which helps to slow their spreading into the body.
PRESCRIBED FOR
The drug Rolimus 5mg is mainly used for the treatment of the following disease
• kidney carcinoma
• Breast carcinoma
• Brain carcinoma
Rolimus 5mg is also used to treat various advanced-stage cancer in the stomach, intestines or pancreas.
MECHANISM
Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to a stoppage of cell progression from G1 into the S phase, finally causes cell growth arrest and apoptosis. Rolimus also prohibits the expression of hypoxia-inducible factors, causing a reduces in the expression of vascular endothelial growth factor. The result of the everolimus prevention of mTOR is a reduction in cell multiplication, angiogenesis, and glucose uptake.
DOSAGE
Rolimus 5mg tablets should be given with or without food.
The dosage regimen of Rolimus:
In breast cancer, renal cell cancer, pancreatic cancer, Neuroendocrine cancer
The prescribed dosage is 10mg should be taken as a single dose. In Brain or intracranial cancer
The prescribed dosage of Rolimus as a single dose. is 4.5mg/m2 given orally
In pediatric:
The pediatric dosage of Rolimus as a single dose in the brain or intracranial tumor is 4.5mg/m2 should be given orally.
SIDE EFFECTS
• Nephrotoxicity
• Thrombocytopenia
• Hypersensitivity reactions
• Hyperlipemia
• Angioedema
• Lymphomas & other malignancy
• Male infertility
DRUG-DRUG INTERACTION
Interaction of Rolimus 5mg with strong inhibitor of CYP3A4, or P-gp, cause reducing the efflux of Everolimus and high plasma concentration of Everolimus.
Concomitant use of Rolimus 5mg with strong CYP3A4 inducers will be increasing the disclosure of Everolimus.
Interaction of Rolimus 5mg with cyclosporine will be increasing the AUC level of Everolimus frequently. Interaction of ketoconazole with Rolimus 5mg tablet or other CYP3A4 inhibitors will increase the plasma concentration and AUC of Everolimus.
PREGNANCY
Pregnancy category of Everolimus C: In patients, Rolimus 5mg is used only after knowing the benefits to the mother exceed the risk to the fetus.
LACTATION
Breastfeeding should not be suggested
STORAGE
Rolimus 5mg tablet store at 25°C
Protect the drugs removed from wetness, heat, and light.
MISSED DOSE
If the patients missed the dose, patients must consult with the medical practitioner and follow the instructions given by them. Or missed dose should be avoided and follow the regular dosing schedule.
You can contact Medatdoorstep for Fast Online Medicine Delivery in Dehradun and for more information email us at medatdoorstepind@gmail.com
https://medatdoorstep.com
ReplyDelete